ArticlePloS one2013

Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.

Andrew R Crow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.